| Title |
Date |
Price |
|
Test Strip Margins and Revenues Decide Profitability in 'Free Meter' MarketOften described as a 'free meter market', the glucose self-monitoring business is characterized by heavy discounts for the meters... |
Mar, 2003 |
€2 951 |
|
Education Campaigns on Seriousness of Diabetes to Increase Usage of HbA1c MonitorsDissemination of information on the graveness of diabetes is expected to do away with the popular perception of the disease... |
Apr, 2003 |
€2 951 |
|
Nuclear gamma cameras are a very important imaging modality for molecular imaging and their strength lies mainly in the large global installed base and the availability of longer half-life radioisotopes... |
Jun, 2004 |
€3 699 |
|
Rise in Laboratory Funding and an Improved Economy Propel Demand for InstrumentationResearchers prefer solutions offered by nucleic acid and liquid handling research instruments to meet the stringent demands... |
Sep, 2004 |
€3 699 |
|
This Frost & Sullivan research service entitled European Clinical Diagnostics Automation Markets provides an overview of automated solutions available for clinical diagnostic laboratories together with... |
Mar, 2006 |
€4 857 |
|
This Frost & Sullivan research service entitled Asia Pacific Digital and Computed Radiography Markets provides an overview of the entire digital X-Ray markets in Asia, with extensive discussions on the... |
Jun, 2006 |
€4 483 |
|
The Frost & Sullivan research service entitled Advances in Mammography provides information on the digital mammography, CAD systems, and tomosynthesis systems sectors. In this research service, Frost &... |
Mar, 2006 |
€4 483 |
|
Diagnostic imaging modalities are seeing increased demand for novel technologies, similar to the market surge for open magnetic resonance imaging (MRI) systems in the late 1990s. The current trend favors... |
Jul, 2004 |
€3 400 |
|
The new report examines the reality of laboratories and hospitals in 6 European countries and provides you with following information:Molecular Tests - Description of laboratory landscape per country -... |
Aug, 2004 |
€4 500 |
|
Obesity, Cardiovascular, and Autoimmune Diseases Stimulate Demand for Sleep Monitoring DevicesRecent research shows a strong correlation between age and obesity and degenerative diseases. Changes in neurological... |
Mar, 2003 |
€3 325 |
|
This Frost & Sullivan research service titled Advances in Laboratory Automation Markets in Europe provides an analysis on the key drivers, industry challenges, restraints, principal trends and revenue... |
Jun, 2006 |
€4 857 |
|
This report analyzes the major segments in the environmental laboratory testing service markets, including air quality, stack emissions, soil, water, solid waste, effluent, public health and product testing... |
May, 1999 |
€3 250 |
|
Emerging Asian Economies Provide Growth Opportunities to IVD Market ParticipantsIn vitro diagnostics (IVD) is one of the most exciting segments in global healthcare and the Asian IVD markets have been... |
Sep, 2004 |
€3 699 |
|
Laboratory Testing Still Regarded as a Cost CentreIn vitro diagnostics (IVD) have traditionally been offered a raw deal by the medical fraternity who considered it inconsequential to long-term or direct... |
Oct, 2004 |
€3 699 |
|
Global Cost Containment Efforts and Economic Constraints Limit Growth of MarketWhile the In Vitro Diagnostics (IVD) segment represents only 2-3% of total healthcare expenses, it is still greatly affected... |
May, 2005 |
€7 435 |
|
In Vitro Diagnostic (IVD) Directive aims to Regulate and Standardise IVD Products With up to 80 per cent of medical decisions being based on laboratory diagnostics, IVD test results are a vital aspect... |
Nov, 2005 |
€3 736 |
|
Encouraging Reimbursement Drives Investment in Fusion Technology Fusion technology has tremendous potential in diagnostic imaging to detect numerous conditions such as tumors, Alzheimer’s disease,... |
Sep, 2005 |
€3 400 |
|
The Medical and Diagnostic Imaging Technology (MDIT) Alert is Frost & Sullivan's latest technology subscription, which leverages our traditional competencies in healthcare technology and market research.... |
Dec, 2005 |
€5 604 |
|
Significant Product Benefits to Break Down Customer Reluctance toward Adopting New Assays End-user skepticism regarding the reliability of new assays for in-vitro diagnostics can be remedied with effective... |
Sep, 2005 |
€3 400 |
|
This report gives extensive data on how often Americans test their cholesterol, their cholesterol level, usage of specific cholesterol control drugs, supplements and herbs, and views on the need to control... |
Dec, 2005 |
€1 097 |